Companies: 10,795·Total market cap: $144.5T
Arcadia Biosciences, Inc.

Arcadia Biosciences, Inc.

RKDANASDAQBasic Materials● Active
$0.96
$-0.11(-10.29%)
Market Cap$1485270
P/E Ratio
52W High$6.71
52W Low$0.8

Arcadia Biosciences, Inc.(RKDA)股价预测与分析师目标价

华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。

rkda · 股价预测 · 5 位分析师(近3月)· FMP · 更新于 2026年6月8日

分析师评级与共识

基于过去 3 个月内 5 位华尔街分析师

SellBuy

Buy

5 位分析师

共识

评级分布

Strong Buy
0
Buy
4
Hold
1
Sell
0
Strong Sell
0
合计: 5 · 买入占比: 80.0%

12 个月目标价

High

$6.00

Consensus

$6.00

+525.1% upside

Low

$6.00

Median: $6 · Last Close: $0.96

Arcadia Biosciences, Inc.(RKDA)的分析师共识为 Buy,基于过去 3 个月内 5 位华尔街分析师的评级。RKDA 的 12 个月平均目标价为 $6.00,相对当前价 $0.96 代表 +525.1% 的潜在上行空间。

12 个月目标价预测

历史收盘价 + 分析师 12 个月目标价预测区间

分析师目标价覆盖不足,无法为该股票生成预测图表。

短期股价预测

⚠️ 短期模型暂不可用——近期成交量过低,信号不可靠。

长期股价预测

⚠️ 长期模型暂不可用——成交量过低,信号不可靠。

基于技术分析的股价预测

14 项技术面信号(SMA×6 + EMA×6 + RSI + MACD)· EEAT 方法论透明

Market Sentiment

BEARISH

Based on 14 technical indicators

0%21%79%
0Buy
3Neutral
11Sell
RSI (14)52.5Neutral
MACDBEARISH

Refreshes daily from EOD close

Moving Averages · RKDA · Jun 8, 2026

Simple Moving Average (SMA)
MA 5$1.01SELL
MA 10$0.97SELL
MA 20$0.98SELL
MA 50$1.12SELL
MA 100$1.52SELL
MA 200$0.00NEUTRAL
Current $RKDA · Price above MA = BUY signal
Exponential Moving Average (EMA)
EMA 5$1.00SELL
EMA 10$0.99SELL
EMA 20$1.01SELL
EMA 50$1.19SELL
EMA 100$1.67SELL
EMA 200$0.00NEUTRAL
Current $RKDA · Price above MA = BUY signal
How we calculate: Technical sentiment is derived from 14 indicators — SMA(5,10,20,50,100,200), EMA(5,10,20,50,100,200), RSI(14), and MACD(12,26,9) — calculated from historical EOD price data. BUY = current price above MA; SELL = below. 14 TA signals + historical EOD price data · Updated daily. Independent of analyst consensus data. Not investment advice.

最新分析师评级与调整

Filter:
HC Wainwright & Co.2024-08-21
Maintains
BuyBuy
HC Wainwright & Co.2024-05-23
Maintains
BuyBuy
HC Wainwright & Co.2024-04-05
Maintains
BuyBuy
HC Wainwright & Co.2023-08-28
Maintains
BuyBuy
HC Wainwright & Co.2023-07-24
Maintains
BuyBuy
HC Wainwright & Co.2023-06-05
Maintains
BuyBuy
HC Wainwright & Co.2023-04-14
Maintains
BuyBuy
HC Wainwright & Co.2022-08-26
Maintains
BuyBuy
HC Wainwright & Co.2022-01-03
Maintains
BuyBuy
HC Wainwright & Co.2021-06-01
Maintains
BuyBuy

Wall Street analysts have recently issued updated ratings on Arcadia Biosciences, Inc. (RKDA) stock. Of the recent 17 rating actions, 0 were upgrades and 1 were downgrades. 5 analysts currently cover RKDA.

分析师推荐趋势

Buy ratings11
Hold ratings00
Sell ratings00

RKDA analyst recommendation trends show stable buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 1 per month.

财务预测:EPS 与营收一致预期

Revenue This Year

$11M

↑ 120.9% YoY

Revenue Next Year

$5M

↓ 52.3% YoY

EPS This Year

$-26.40

EPS Next Year

$-5.89

↓ 77.7% YoY

EPS ForecastReported vs Estimated

Reported EPSHistorical estimateAnalyst forecast (future)

Analysts forecast RKDA EPS of $-26.40 for the current fiscal year, based on estimates from 1 analysts. The RKDA revenue forecast is $11M for the current year. These are analyst consensus estimates via FMP / S&P Global.

关于预测与目标价

RKDA 股价预测由两类独立数据源支撑:来自 5 位华尔街分析师(S&P Global / FMP)的共识评级,以及基于历史日终价计算的技术分析。RKDA 的共识目标价为 $6.00(+525.1% 上行空间),分析师共识为 Buy。

Arcadia Biosciences, Inc. 在 NASDAQ 上市,代码 RKDA。RKDA 在 2027 年的整体展望偏积极,在覆盖分析师中约 80% 对应 Buy 共识。

常见问题答案综合分析师目标价、一致预期及页面展示的模型结果。

常见问题

RKDA 预测 · 8 个问题

根据 5 位华尔街分析师,RKDA 的 12 个月平均目标价为 $6.00,最高 $6.00、最低 $6.00。若有图表,中位目标价可在上方查看。相对当前价 $0.96,隐含约 +525.1% 的上行空间。

RKDA 目标价RKDA 分析师目标价RKDA 12个月目标价目标价 RKDA

· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)

⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.